Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy R Jass

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2006
Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potentialTamara L Znajda, Shinichi Hayashi, Peter J Horton, et al.
Oncology Reports|March 8, 2007
Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South AfricaNirmitha I Herath, Michael D Walsh, Michael Kew, et al.
Pathology|January 31, 2003
Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genesJoanne Young, Melissa Barker, Leigh Fraser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer casesTakeshi Nagasaka, Gerald B Sharp, Kenji Notohara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancerTakeshi Kambara, Gerald B Sharp, Takeshi Nagasaka, et al.
BMC Cancer|October 26, 2006
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancersJune A Chia, Lisa A Simms, Sarah-Jane Cozzi, et al.
The Journal of Pathology|September 2, 2003
Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability statusJulie M Michael-Robinson, Nirmala Pandeya, Margaret C Cummings, et al.
International Journal of Cancer|May 23, 2009
HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancersMichael D Walsh, Owen F Dent, Joanne P Young, et al.
Human Pathology|October 27, 2007
The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instabilityAileen M Houston, Julie M Michael-Robinson, Michael D Walsh, et al.
Cancer Research|November 5, 2002
Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancerVicki L J Whitehall, Coral V A Wynter, Michael D Walsh, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2006
Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potentialTamara L Znajda, Shinichi Hayashi, Peter J Horton, et al.
Oncology Reports|March 8, 2007
Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South AfricaNirmitha I Herath, Michael D Walsh, Michael Kew, et al.
Pathology|January 31, 2003
Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genesJoanne Young, Melissa Barker, Leigh Fraser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer casesTakeshi Nagasaka, Gerald B Sharp, Kenji Notohara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancerTakeshi Kambara, Gerald B Sharp, Takeshi Nagasaka, et al.
BMC Cancer|October 26, 2006
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancersJune A Chia, Lisa A Simms, Sarah-Jane Cozzi, et al.
The Journal of Pathology|September 2, 2003
Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability statusJulie M Michael-Robinson, Nirmala Pandeya, Margaret C Cummings, et al.
International Journal of Cancer|May 23, 2009
HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancersMichael D Walsh, Owen F Dent, Joanne P Young, et al.
Human Pathology|October 27, 2007
The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instabilityAileen M Houston, Julie M Michael-Robinson, Michael D Walsh, et al.
Cancer Research|November 5, 2002
Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancerVicki L J Whitehall, Coral V A Wynter, Michael D Walsh, et al.
Pageof 8